Figure 2From: Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis Disease-free survival at 60Â months for patients who underwent hyperthermic intraperitoneal chemotherapy (HIPEC) and those who had a negative second-look surgery. Back to article page